IITRI NEWS

NEWS

We are ready to answer your questions and provide guidance.

News

IITRI Awarded Over $4.7M BARDA Contracts

IITRI announces the recent award of three major new programs by the Biomedical Advanced Research and Development Authority (BARDA) valued at more than $4.7 M. The programs are for the development and/or evaluation of cutting edge technologies and agents to control...

IITRI Co-authors ASCO 2016 Poster with Singh Biotechnology, LLC

ASCO 2016 Poster Presented IITRI co-authored a poster presented at the recent American Society of Clinical Oncology (ASCO) meeting in Chicago, IL. The poster, A novel single domain antibody (sdAb) SBT-100 to target intracellular STAT3 to affect growth and regression...

IITRI Announces Membership in NCBD Consortium

IITRI Joins National Chemical & Biological Defense Consortium IITRI is pleased to announce our acceptance as a member into the National Chemical & Biological Defense Consortium (NCBDC). The mission of the Consortium will be to provide the US Department of...

IITRI Announces Zika Mouse Model Available

IITRI is on the leading edge for testing new Zika vaccines and antivirals CHICAGO, May 9, 2016 /PRNewswire-USNewswire/ -- IIT Research Institute (IITRI) scientists have developed a novel mouse model for Zika infections using the current viral strain responsible for...

IITRI Welcomes Robert Baker PhD as Division Manager

Please join us in welcoming Robert Baker, PhD as Division Manager. We’re pleased to announce Robert Baker, PhD as Assistant Vice President and Manager of the Microbiology and Molecular Biology Division at IITRI. Dr. Baker brings over 15 years of regulatory...

IITRI Awarded $9 million NCI PREVENT Cancer Program Contract

IIT Research Institute has been awarded a contract for up to $9 million for preclinical services to support the National Cancer Institute (NCI) Preclinical PREVENT Cancer Program - Toxicology and Pharmacology Testing. This NCI program was initiated to bring new...

IITRI’s Clinical Trial Support Services In the News

IITRI offers a wide range of bioanalytical services for the detection and quantification of both small molecule and biologic drug candidates from human clinical trial samples. Two recent publications highlight our experience in determining drug and hormone...